Circulating extracellular vesicles as new inflammation marker in HIV infection.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
15 03 2021
15 03 2021
Historique:
pubmed:
12
12
2020
medline:
29
4
2021
entrez:
11
12
2020
Statut:
ppublish
Résumé
Extracellular vesicles, released by cell pullulation, are surrounded by a phospholipid bilayer and carry proteins as well and genetic material. It has been shown that extracellular vesicles mediate intercellular communication in several conditions, such as inflammation, immunodeficiency, tumor growth, and viral infections. Here, we analyzed circulating levels of extracellular vesicles in order to clarify their role in chronic inflammation mechanisms characterizing HIV patients. We analyzed and subtyped circulating levels of extracellular vesicles, through a recently developed flow cytometry method. In detail, endothelial-derived extracellular vesicles (CD31+/CD41a-/CD45-, EMVs), extracellular vesicles stemming from leukocytes (CD45+, LMVs) and platelets (CD41a+/CD31+) were identified and enumerated. Moreover, we analyzed the extracellular vesicle protein cargo with proteomic analysis. Circulating levels of total extracellular vesicles, EMVs and LMVs were significantly lower in the HIV+ patients than in healthy subjects, whereas platelet-derived extracellular vesicles resulted higher in patients than in the healthy population. Proteomic analysis showed the upregulation of gammaIFN and IL1α, and down-regulation of OSM, NF-kB, LIF, and RXRA signaling resulted activated in this patients. These data demonstrate, for the first time that HIV infection induces the production of extracellular vesicles containing mediators that possibly feed the chronic inflammation and the viral replication. These two effects are connected as the inflammation itself induces the viral replication. We, therefore, hypothesize that HIV infection inhibits the production of extracellular vesicles that carry anti-inflammatory molecules.
Sections du résumé
BACKGROUND
Extracellular vesicles, released by cell pullulation, are surrounded by a phospholipid bilayer and carry proteins as well and genetic material. It has been shown that extracellular vesicles mediate intercellular communication in several conditions, such as inflammation, immunodeficiency, tumor growth, and viral infections. Here, we analyzed circulating levels of extracellular vesicles in order to clarify their role in chronic inflammation mechanisms characterizing HIV patients.
METHODS
We analyzed and subtyped circulating levels of extracellular vesicles, through a recently developed flow cytometry method. In detail, endothelial-derived extracellular vesicles (CD31+/CD41a-/CD45-, EMVs), extracellular vesicles stemming from leukocytes (CD45+, LMVs) and platelets (CD41a+/CD31+) were identified and enumerated. Moreover, we analyzed the extracellular vesicle protein cargo with proteomic analysis.
RESULTS
Circulating levels of total extracellular vesicles, EMVs and LMVs were significantly lower in the HIV+ patients than in healthy subjects, whereas platelet-derived extracellular vesicles resulted higher in patients than in the healthy population. Proteomic analysis showed the upregulation of gammaIFN and IL1α, and down-regulation of OSM, NF-kB, LIF, and RXRA signaling resulted activated in this patients.
CONCLUSION
These data demonstrate, for the first time that HIV infection induces the production of extracellular vesicles containing mediators that possibly feed the chronic inflammation and the viral replication. These two effects are connected as the inflammation itself induces the viral replication. We, therefore, hypothesize that HIV infection inhibits the production of extracellular vesicles that carry anti-inflammatory molecules.
Identifiants
pubmed: 33306552
pii: 00002030-202103150-00008
doi: 10.1097/QAD.0000000000002794
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
595-604Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Simeone P, Bologna G, Lanuti P, Pierdomenico L, Guagnano MT, Pieragostino D, et al. Extracellular vesicles as signaling mediators and disease biomarkers across biological barriers . Int J Mol Sci 2020; 21:2154.
Ciccocioppo F, Lanuti P, Marchisio M, Miscia S. Extracellular vesicles involvement in the modulation of the glioblastoma environment . J Oncol 2020; 2020:3961735.
Franzago M, Lanuti P, Fraticelli F, Marchioni M, Buca D, Di Nicola M, et al. Biological insight into the extracellular vesicles in women with and without gestational diabetes . J Endocrinol Invest 2020; 32335856.
Buca D, Bologna G, D’Amico A, Cugini S, Musca F, Febbo M, et al. Extracellular vesicles in feto-maternal crosstalk and pregnancy disorders . Int J Mol Sci 2020; 21:2120.
Bang C, Thum T. Exosomes: new players in cell-cell communication . Int J Biochem Cell Biol 2012; 44:2060–2064.
Cufaro MC, Pieragostino D, Lanuti P, Rossi C, Cicalini I, Federici L, et al. Extracellular vesicles and their potential use in monitoring cancer progression and therapy: the contribution of proteomics . J Oncol 2019; 2019:1639854.
Pieragostino D, Lanuti P, Cicalini I, Cufaro MC, Ciccocioppo F, Ronci M, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis . J Proteomics 2019; 204:103403.
Ciardiello C, Leone A, Lanuti P, Roca MS, Moccia T, Minciacchi VR, et al. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation . J Exp Clin Cancer Res 2019; 38:317.
Grande R, Dovizio M, Marcone S, Szklanna PB, Bruno A, Ebhardt HA, et al. Platelet-derived microparticles from obese individuals: characterization of number, size, proteomics, and crosstalk with cancer and endothelial cells . Front Pharmacol 2019; 10:7.
Brocco D, Lanuti P, Simeone P, Bologna G, Pieragostino D, Cufaro MC, et al. Circulating cancer stem cell-derived extracellular vesicles as a novel biomarker for clinical outcome evaluation . J Oncol 2019; 2019:5879616.
Lanuti P, Santilli F, Marchisio M, Pierdomenico L, Vitacolonna E, Santavenere E, et al. A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction . J Immunol Methods 2012; 380:16–22.
Santilli F, Marchisio M, Lanuti P, Boccatonda A, Miscia S, Davi G. Microparticles as new markers of cardiovascular risk in diabetes and beyond . Thromb Haemost 2016; 116:220–234.
da Silva EF, Fonseca FA, Franca CN, Ferreira PR, Izar MC, Salomao R, et al. Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy . AIDS 2011; 25:1595–1601.
Amabile N, Cheng S, Renard JM, Larson MG, Ghorbani A, McCabe E, et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study . Eur Heart J 2014; 35:2972–2979.
Poon IKH, Parkes MAF, Jiang L, Atkin-Smith GK, Tixeira R, Gregory CD, et al. Moving beyond size and phosphatidylserine exposure: evidence for a diversity of apoptotic cell-derived extracellular vesicles in vitro . J Extracell Vesicles 2019; 8:1608786.
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis . Nature 2015; 527:329–335.
Pieragostino D, Cicalini I, Lanuti P, Ercolino E, di Ioia M, Zucchelli M, et al. Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of multiple sclerosis patients . Sci Rep 2018; 8:3071.
Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines . J Extracell Vesicles 2018; 7:1535750.
Falasca K, Reale M, Di Nicola M, Ucciferri C, Zecca IA, Santilli F, et al. Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients . HIV Med 2019; 20:681–690.
Falasca K, Di Nicola M, Di Martino G, Ucciferri C, Vignale F, Occhionero A, Vecchiet J. The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects . BMC Infect Dis 2019; 19:105.
Teofili L, Nuzzolo ER, Vecchiet J, Falasca K, Iachininoto MG, Martini M, Larocca LM. Endothelial progenitor cells in HIV-positive patients: what are we talking about? . J Acquir Immune Defic Syndr 2013; 62:e22–e23.
Vecchiet J, Iachininoto MG, Capodimonti S, Nuzzolo ER, Falasca K, Martini M, et al. Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people . Thromb Res 2013; 131:238–243.
Lopez M, San Roman J, Estrada V, Vispo E, Blanco F, Soriano V. Endothelial dysfunction in HIV infection--the role of circulating endothelial cells, microparticles, endothelial progenitor cells and macrophages . AIDS Rev 2012; 14:223–230.
Grand M, Bia D, Diaz A. Cardiovascular risk assessment in people living with HIV: a systematic review and meta-analysis of real-life data . Curr HIV Res 2020; 18:5–18.
Falasca K, Ucciferri C, Mancino P, Di Iorio A, Vignale F, Pizzigallo E, Vecchiet J. Cystatin C, adipokines and cardiovascular risk in HIV infected patients . Curr HIV Res 2010; 8:405–410.
Corrales-Medina VF, Simkins J, Chirinos JA, Serpa JA, Horstman LL, Jy W, Ahn YS. Increased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapy . J Acquir Immune Defic Syndr 2010; 54:217–218.
Puca V, Ercolino E, Celia C, Bologna G, Di Marzio L, Mincione G, et al. Detection and quantification of eDNA-associated bacterial membrane vesicles by flow cytometry . Int J Mol Sci 2019; 20:5307.
Cossarizza A, Chang HD, Radbruch A, Acs A, Adam D, Adam-Klages S, et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) . Eur J Immunol 2019; 49:1457–1973.
Rossi C, Cicalini I, Cufaro MC, Agnifili L, Mastropasqua L, Lanuti P, et al. Multi-omics approach for studying tears in treatment-naive glaucoma patients . Int J Mol Sci 2019; 20:31426571.
Welch JL, Kaddour H, Winchester L, Fletcher CV, Stapleton JT, Okeoma CM. Semen extracellular vesicles from HIV-1-infected individuals inhibit HIV-1 replication in vitro, and extracellular vesicles carry antiretroviral drugs in vivo . J Acquir Immune Defic Syndr 2020; 83:90–98.
Falasca K, Ucciferri C, Teofili L, Iachininoto MG, Capodimonti S, Nuzzolo ER, et al. Short communication: proangiogenic hematopoietic cells in acute HIV infection . AIDS Res Hum Retroviruses 2013; 29:307–310.
Tanaka M, Miyajima A. Oncostatin M, a multifunctional cytokine . Rev Physiol Biochem Pharmacol 2003; 149:39–52.
Vecchiet J, Dalessandro M, Falasca K, Di Iorio A, Travasi F, Zingariello P, et al. Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS . J Acquir Immune Defic Syndr 2003; 32:464–465.
Onishi K, Zandstra PW. LIF signaling in stem cells and development . Development 2015; 142:2230–2236.
Gilmore TD. The Rel/NF-kappaB signal transduction pathway: introduction . Oncogene 1999; 18:6842–6844.
Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system . Annu Rev Immunol 1994; 12:141–179.
Yu XH, Zhang J, Zheng XL, Yang YH, Tang CK. Interferon-gamma in foam cell formation and progression of atherosclerosis . Clin Chim Acta 2015; 441:33–43.
Vromman A, Ruvkun V, Shvartz E, Wojtkiewicz G, Santos Masson G, Tesmenitsky Y, et al. Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis . Eur Heart J 2019; 40:2482–2491.
Snopkova S, Matyskova M, Havlickova K, Jarkovsky J, Svoboda M, Zavrelova J, et al. Increasing procoagulant activity of circulating microparticles in patients living with HIV . Med Mal Infect 2019; 50:555–561.
Perez E, Bourguet W, Gronemeyer H, de Lera AR. Modulation of RXR function through ligand design . Biochim Biophys Acta 2012; 1821:57–69.
Roszer T, Menendez-Gutierrez MP, Cedenilla M, Ricote M. Retinoid X receptors in macrophage biology . Trends Endocrinol Metab 2013; 24:460–468.
Ma F, Liu SY, Razani B, Arora N, Li B, Kagechika H, et al. Retinoid X receptor alpha attenuates host antiviral response by suppressing type I interferon . Nat Commun 2014; 5:5494.